Kidney Profile Test - Expanded
- $535.32
- $149.95
- Save: 71.99%
The following is a list of what is included in the item above. Click the test(s) below to view what biomarkers are measured along with an explanation of what the biomarker is measuring.
Also known as: Microalbumin Random Urine with Creatinine
Creatinine, Random Urine
Microalbumin
Microalbumin/Creatinine
Also known as: CBC, CBC includes Differential and Platelets, CBC/PLT w/DIFF, Complete Blood Count (includes Differential and Platelets)
NOTE: Ulta Lab Tests provides CBC test results from Quest Diagnostics as they are reported. Often, different biomarker results are made available at different time intervals. When reporting the results, Ulta Lab Tests denotes those biomarkers not yet reported as 'pending' for every biomarker the test might report. Only biomarkers Quest Diagnostics observes are incorporated and represented in the final CBC test results provided by Ulta Lab Tests.
Absolute Band Neutrophils (Only Reported If Detected)
Absolute Basophils
Absolute Blasts (Only Reported If Detected)
Absolute Eosinophils
Absolute Lymphocytes
Absolute Metamyelocytes (Only Reported If Detected)
Absolute Monocytes
Absolute Myelocytes (Only Reported If Detected)
Absolute Neutrophils
Absolute Nucleated Rbc (Only Reported If Detected)
Absolute Promyelocytes (Only Reported If Detected)
Band Neutrophils (Only Reported If Detected)
Basophils
Blasts (Only Reported If Detected)
Eosinophils
Hematocrit
Hemoglobin
Lymphocytes
MCH
MCHC
MCV
Metamyelocytes (Only Reported If Detected)
Monocytes
MPV
Myelocytes (Only Reported If Detected)
Neutrophils
Nucleated Rbc (Only Reported If Detected)
Platelet Count
Promyelocytes (Only Reported If Detected)
RDW
Reactive Lymphocytes (Only Reported If Detected)
Red Blood Cell Count
White Blood Cell Count
Also known as: Chem 12, Chemistry Panel, Chemistry Screen, CMP, Complete Metabolic Panel, Comprehensive Metabolic Panel CMP, SMA 12, SMA 20
Albumin
Albumin/Globulin Ratio
Alkaline Phosphatase
Alt
AST
Bilirubin, Total
Bun/Creatinine Ratio
Calcium
Carbon Dioxide
Chloride
Creatinine
Egfr African American
Egfr Non-Afr. American
GFR-AFRICAN AMERICAN
GFR-NON AFRICAN AMERICAN
Globulin
Glucose
Potassium
Protein, Total
Sodium
Urea Nitrogen (Bun)
CYSTATIN C
eGFR
Also known as: UA, Complete, Urinalysis UA Complete, Urine Analysis, Complete
Amorphous Sediment (Only Reported If Detected)
Appearance
Bacteria
Bilirubin
Calcium Oxalate Crystals (Only Reported If Detected)
Casts (Only Reported If Detected)
Color
Crystals (Only Reported If Detected)
Glucose
Granular Cast (Only Reported If Detected)
Hyaline Cast
Ketones
Leukocyte Esterase
Nitrite
Occult Blood
Ph
Protein
Rbc
Reducing Substances (Only Reported If Detected)
Renal Epithelial Cells (Only Reported If Detected)
Specific Gravity
Squamous Epithelial Cells
Transitional Epithelial (Only Reported If Detected)
Triple Phosphate Crystals (Only Reported If Detected)
Uric Acid Crystals (Only Reported If Detected)
WBC
YEAST (Only Reported If Detected)
The Kidney Profile Test - Expanded panel contains 5 tests with 86 biomarkers .
The Kidney Profile Test - Expanded is a comprehensive diagnostic panel designed to evaluate kidney function, detect early signs of kidney damage, and monitor ongoing renal conditions. This test panel combines blood and urine assessments that analyze kidney filtration ability, structural integrity, waste elimination efficiency, and related systemic health indicators. It goes beyond basic kidney screening by including advanced biomarkers such as cystatin C, which can offer more accurate insights into glomerular filtration rate (GFR) even when serum creatinine may be misleading. Additionally, the panel provides a broader view of the patient's metabolic state, hydration status, protein loss, and blood cell health—all of which contribute to a thorough understanding of renal and overall systemic health.
Kidney Profile Test - Expanded: When and Why It May Be Ordered
A healthcare provider may order the Kidney Profile Test - Expanded for patients experiencing symptoms of kidney dysfunction such as swelling in the legs or face, changes in urination, fatigue, high blood pressure, or unexplained electrolyte imbalances. It is also frequently ordered for patients with known risk factors for kidney disease, including diabetes, hypertension, heart disease, or a family history of renal problems. This panel is used both for initial screening and for ongoing monitoring of chronic kidney disease (CKD), especially when assessing disease progression or evaluating the effectiveness of treatment strategies. Its inclusion of more sensitive markers like cystatin C makes it particularly useful in early detection of renal impairment before conventional tests show abnormalities.
Kidney Profile Test - Expanded: What the Panel Checks For
The Kidney Profile Test - Expanded evaluates kidney health by measuring several key parameters in both blood and urine. Together, these tests offer a detailed picture of kidney structure, function, and the presence of inflammation or damage.
Albumin, Random Urine with Creatinine:
This test detects and quantifies the amount of albumin (a type of protein) present in a urine sample and compares it to the urine creatinine level to calculate the albumin-to-creatinine ratio (ACR). An elevated ACR may be one of the earliest signs of kidney damage, especially in people with diabetes or hypertension. It helps assess how well the kidneys are filtering and retaining important proteins.
Complete Blood Count (CBC) with Differential and Platelets:
The CBC evaluates red and white blood cells and platelet levels, which can help detect anemia—a common complication of chronic kidney disease due to decreased erythropoietin production by the kidneys. It can also reveal signs of infection or inflammation that might indicate underlying kidney conditions or systemic disease affecting kidney function.
Comprehensive Metabolic Panel (CMP):
The CMP assesses blood levels of electrolytes (like sodium, potassium, and bicarbonate), glucose, calcium, albumin, and waste products such as blood urea nitrogen (BUN) and creatinine. It provides critical information about kidney filtration capacity and metabolic balance. Creatinine levels from this panel are used to estimate glomerular filtration rate (eGFR), a key indicator of kidney function.
Cystatin C with eGFR:
Cystatin C is a low-molecular-weight protein produced by all nucleated cells and filtered out of the bloodstream by the kidneys. Unlike creatinine, it is not significantly influenced by muscle mass, age, or gender, making it a more sensitive and reliable marker of kidney function in certain populations. The cystatin C-based eGFR calculation can detect early decreases in filtration rate, especially when creatinine-based eGFR appears normal.
Urinalysis, Complete:
This test provides a comprehensive overview of urine characteristics, including color, clarity, pH, specific gravity, and the presence of glucose, ketones, blood, protein, leukocyte esterase, nitrites, and microscopic elements such as cells and crystals. Abnormal findings can indicate urinary tract infections, kidney inflammation (glomerulonephritis), or other renal conditions.
Kidney Profile Test - Expanded: Conditions or Diseases It Can Detect
The Kidney Profile Test - Expanded is used to detect, diagnose, and monitor several kidney-related and systemic conditions. It is particularly valuable for identifying early kidney damage, chronic kidney disease, and complications arising from metabolic or cardiovascular disorders.
Chronic Kidney Disease (CKD):
CKD is a progressive loss of kidney function over time. It often begins silently, with early stages showing little to no symptoms. The combination of eGFR (from both creatinine and cystatin C), elevated urine albumin, and abnormal metabolic markers in this panel can help detect CKD in its earliest stages. Persistent abnormalities support a diagnosis and help stage the disease, which is critical for managing progression and reducing complications.
Diabetic Nephropathy:
This is kidney damage resulting from long-standing diabetes. It is characterized by protein leakage in the urine, often beginning as microalbuminuria. The urine albumin-to-creatinine ratio and other renal markers in the panel provide early warning signs. Over time, kidney filtration declines, making cystatin C and eGFR key tools in tracking the disease.
Hypertensive Nephrosclerosis:
Chronic high blood pressure can damage blood vessels in the kidneys, leading to structural and functional impairment. This panel helps detect the effects of hypertension through elevated creatinine, reduced eGFR, and possible proteinuria. Monitoring these markers helps clinicians adjust antihypertensive therapy and prevent further kidney damage.
Glomerulonephritis:
This refers to inflammation of the glomeruli—the filtering units of the kidney. It often presents with hematuria (blood in urine), proteinuria, and decreased kidney function. The complete urinalysis and CBC (which may show signs of systemic inflammation or anemia) provide supportive diagnostic clues, while metabolic markers and cystatin C track renal involvement.
Acute Kidney Injury (AKI):
AKI is a sudden decline in kidney function, often caused by dehydration, toxins, infection, or medications. The panel’s metabolic tests (e.g., BUN, creatinine), electrolyte levels, and urinalysis results help confirm the diagnosis and identify potential causes. Elevated cystatin C levels may also support early detection.
Kidney Profile Test - Expanded: How Results Are Used in Treatment or Monitoring
Chronic Kidney Disease (CKD):
In patients with confirmed CKD, this panel allows for ongoing assessment of kidney function, electrolyte balance, and protein excretion. It helps providers track disease progression and make timely adjustments to medications (e.g., ACE inhibitors, ARBs) and dietary interventions. Cystatin C provides a more precise measurement of kidney filtration in patients where creatinine-based estimates may be unreliable.
Diabetic Nephropathy:
Results from the urine albumin-to-creatinine ratio and metabolic markers help clinicians adjust glycemic control strategies, initiate renoprotective therapies, and manage hypertension. Periodic monitoring is essential to delay disease progression and prevent end-stage renal failure.
Hypertensive Nephrosclerosis:
The panel aids in evaluating whether blood pressure management is effective in preserving kidney health. Elevated protein in the urine or declining eGFR may prompt a change in antihypertensive medication or lifestyle interventions.
Glomerulonephritis:
Treatment often involves immunosuppressive therapy, and this panel is useful for assessing the response to such treatment by tracking protein levels, inflammatory markers, and kidney function. The CBC also monitors for anemia, which is a common complication.
Acute Kidney Injury (AKI):
In AKI, timely identification is critical. This panel enables clinicians to detect abrupt changes in kidney function and monitor for recovery or worsening. Treatment may include fluid management, stopping nephrotoxic drugs, and addressing the underlying cause.
Kidney Profile Test - Expanded: Conclusion
The Kidney Profile Test - Expanded provides a powerful combination of tests that allow healthcare professionals to detect, diagnose, and manage a wide range of kidney-related conditions with a high level of accuracy and insight. By integrating advanced biomarkers like cystatin C with standard renal and metabolic evaluations, this panel offers a sensitive and early detection tool for at-risk patients while also supporting robust disease monitoring and treatment adjustments. Whether the goal is early intervention, long-term management, or differential diagnosis, this panel supports personalized, data-driven care to preserve and protect kidney health.